Clinical trial
A Prospective Randomized, Controlled Clinical Trial on the Efficacy of Cryoinsufflation for the Treatment of Hidradenitis Suppurativa
NCT05830149 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized, Controlled Clinical Trial on the Efficacy of Cryoinsufflation for the Treatment of Hidradenitis Suppurativa
- Lead sponsor
- Henry Ford Health System
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 20, 2018
- Completion date
- April 18, 2018
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.